These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 28506510)

  • 1. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
    Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Occult Invasive Disease in Ductal Carcinoma in Situ Using Deep Learning Features.
    Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    J Am Coll Radiol; 2018 Mar; 15(3 Pt B):527-534. PubMed ID: 29398498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
    Grimm LJ; Neely B; Hou R; Selvakumaran V; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Devalapalli A; Kim C; Soo MS; Hyslop T; Hwang ES; Lo JY
    AJR Am J Roentgenol; 2021 Apr; 216(4):903-911. PubMed ID: 32783550
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of Upstaging in Ductal Carcinoma in Situ Based on Mammographic Radiomic Features.
    Hou R; Grimm LJ; Mazurowski MA; Marks JR; King LM; Maley CC; Lynch T; van Oirsouw M; Rogers K; Stone N; Wallis M; Teuwen J; Wesseling J; Hwang ES; Lo JY
    Radiology; 2022 Apr; 303(1):54-62. PubMed ID: 34981975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Upstaging of DCIS to Invasive Disease: Radiologists's Predictive Performance.
    Selvakumaran V; Hou R; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Lu LX; Devalapalli A; Kim C; Soo MS; Hwang ES; Lo JY; Grimm LJ
    Acad Radiol; 2020 Nov; 27(11):1580-1585. PubMed ID: 32001164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammographic appearance of ductal carcinoma in situ does not reliably predict histologic subtype.
    Slanetz PJ; Giardino AA; Oyama T; Koerner FC; Halpern EF; Moore RH; Kopans DB
    Breast J; 2001; 7(6):417-21. PubMed ID: 11843854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?
    Harowicz MR; Saha A; Grimm LJ; Marcom PK; Marks JR; Hwang ES; Mazurowski MA
    J Magn Reson Imaging; 2017 Nov; 46(5):1332-1340. PubMed ID: 28181348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ.
    Ahn HS; Kim SM; Kim MS; Jang M; Yun B; Kang E; Kim EK; Park SY; Kim B
    Medicine (Baltimore); 2020 Jul; 99(31):e21257. PubMed ID: 32756104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
    Alaeikhanehshir S; Voets MM; van Duijnhoven FH; Lips EH; Groen EJ; van Oirsouw MCJ; Hwang SE; Lo JY; Wesseling J; Mann RM; Teuwen J;
    Cancer Imaging; 2024 Apr; 24(1):48. PubMed ID: 38576031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.
    Stomper PC; Geradts J; Edge SB; Levine EG
    AJR Am J Roentgenol; 2003 Dec; 181(6):1679-84. PubMed ID: 14627596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
    Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD
    J Surg Oncol; 2006 Jun; 93(7):559-63. PubMed ID: 16705731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rate of postoperative upstaging of ductal carcinoma in situ when prioritizing ultrasound evaluation of mammography-detected lesions: a single-center retrospective cohort study.
    Hsieh YC; Lo C; Lee YH; Chien N; Lu TP; Tsai LW; Wang MY; Kuo WH; Chang YC; Huang CS
    World J Surg Oncol; 2023 Feb; 21(1):48. PubMed ID: 36804000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of aggressiveness: risk of progression to invasive breast cancer by mammographic features of calcifications in screen-detected ductal carcinoma in situ.
    Lilleborge M; Falk RS; Hovda T; Holmen MM; Ursin G; Hofvind S
    Acta Radiol; 2022 May; 63(5):586-595. PubMed ID: 33887963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus.
    Wahedna Y; Evans AJ; Pinder SE; Ellis IO; Blamey RW; Geraghty JG
    Eur J Cancer; 2001 Mar; 37(4):459-62. PubMed ID: 11267854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of clinicopathological features on the predictive accuracy of conventional breast imaging in determining the extent of screen-detected high-grade pure ductal carcinoma in situ.
    Hayward L; Oeppen RS; Grima AV; Royle GT; Rubin CM; Cutress RI
    Ann R Coll Surg Engl; 2011 Jul; 93(5):385-90. PubMed ID: 21943463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the association of mammographic density and clinical factors with ductal carcinoma in situ versus invasive ductal breast cancer in Korean women.
    Ko H; Shin J; Lee JE; Nam SJ; Nguyen TL; Hopper JL; Song YM
    BMC Cancer; 2017 Dec; 17(1):821. PubMed ID: 29207971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Analysis Using a Novel CNN Algorithm to Distinguish Atypical Ductal Hyperplasia From Ductal Carcinoma in Situ in Breast.
    Mutasa S; Chang P; Nemer J; Van Sant EP; Sun M; McIlvride A; Siddique M; Ha R
    Clin Breast Cancer; 2020 Dec; 20(6):e757-e760. PubMed ID: 32680766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast ductal carcinoma in situ with micro-invasion versus ductal carcinoma in situ: a comparative analysis of clinicopathological and mammographic findings.
    Zhang M; Lin Q; Su XH; Cui CX; Bian TT; Wang CQ; Zhao J; Li LL; Ma JZ; Huang JL
    Clin Radiol; 2021 Oct; 76(10):787.e1-787.e7. PubMed ID: 34052010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted Breast MRI in Prediction of Upstaging in Women with Biopsy-proven Ductal Carcinoma in Situ.
    Lee SA; Lee Y; Ryu HS; Jang MJ; Moon WK; Moon HG; Lee SH
    Radiology; 2022 Nov; 305(2):307-316. PubMed ID: 35787199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.